Pay My Bill
Careers
Donate
+1 (844) 401-0111
Find A Provider
Services
Addiction & Rehabilitation
Alcohol and Drug Addiction
Opioid Addiction and Recovery Stabilization
Behavioral Health
Mood and Anxiety Disorders: Bipolar and Depression
Obsessive-Compulsive and Anxiety Disorders
Psychotic Disorders: Schizophrenia, Paranoia, and Psychosis
Neurology
Memory Disorders: Alzheimer’s Disease, Dementia, and Memory Loss
Movement Disorders: Parkinson’s Disease, Huntington’s, and Tardive Dyskinesia
Neuropsychology Program
Emergency Assessments
Patients & Visitors
For Healthcare Providers
Research
Contact Us
Services
Addiction & Rehabilitation
Alcohol and Drug Addiction
Opioid Addiction and Recovery Stabilization
Behavioral Health
Mood and Anxiety Disorders: Bipolar and Depression
Obsessive-Compulsive and Anxiety Disorders
Psychotic Disorders: Schizophrenia, Paranoia, and Psychosis
Neurology
Memory Disorders: Alzheimer’s Disease, Dementia, and Memory Loss
Movement Disorders: Parkinson’s Disease, Huntington’s, and Tardive Dyskinesia
Emergency Assessments
Patients & Visitors
For Healthcare Providers
Research
Contact Us
Pay My Bill
Careers
+1 (844) 401-0111
Site Search
MIND Diet Brain-Healthy Bites: Health(ier) Oatmeal Cookies
Read More
13-Aug-2021
MIND Diet Brain-Healthy Bites: Blueberry, Broccoli and Spinach Salad
Read More
27-Jul-2021
Leading Experts Release Recommendations for New Alzheimer’s Drug
Read More
23-Jul-2021
MIND Diet Brain-Healthy Bites: Cod with Kalamata Olive Topping
Read More
23-Jul-2021
Get Walking for Better Brain Health: Favorite RI Walking Trails
Read More
29-Jun-2021
FDA Grants Breakthrough Therapy Designation to Donanemab, Investigational Alzheimer's Drug
Read More
29-Jun-2021
VIDEO: New Advances in Alzheimer's Treatments – Dr. Stephen Salloway on ALZ Talks
Read More
23-Jun-2021
Nature Medicine Publishes Latest Results of Clinical Trial for Dominantly Inherited Alzheimer's
Read More
16-Jun-2021
Butler Hospital Administers World’s First Treatment of New Alzheimer's Drug, Aduhelm
Read More
7-Jun-2021
FDA approves aducanumab, the first drug to meaningfully change the course of Alzheimer’s disease
Read More
5
6
7
8
